LATEST HEALTH NEWS
New phase III RACE trial demonstrates that adding Eltrombopag to standard immunosuppressive treatment is safe and increases response rates in patients with this rare, yet potentially fatal disease.
from Medindia Health News https://ift.tt/3n2hBsk
No comments
Thanks for comment via will connect you within 24 hours.